Pay in 4 interest-free payments of $6.95 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
Take the first step toward a healthier future with medically supervised weight loss
Mounjaro (Tirzepatide) FDA-approved for: Type 2 diabetes in adults and children (ages 10+) Dosing: Once-weekly injection Device: Single-dose pen, multi-dose pen (KwikPen), or vial Mounjaro is not a pure GLP-1 agonist
Rapid cessation may trigger appetite rebound, weight regain, and metabolic dysregulation
Phenomenal Absorption
Adjust the pace or revisit habits
US$ 26.66
US$ 21.00
US$ 23.14
US$ 27.82
